Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 86–86 | Cite as

Bevacizumab

Menstrual cycle abnormality and proteinuria: 6 case reports
Case report
  • 14 Downloads

Reference

  1. Sverak P, et al. Bevacizumab for Hearing Preservation in Neurofibromatosis Type 2: Emphasis on Patient-Reported Outcomes and Toxicities. Otolaryngology - Head and Neck Surgery 160: 526-532, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1177/0194599818809085 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations